Sort
64,565 grants matching “drug discovery”
Engineering biophysical microtechnologies for hematologic applications in health and disease
$769,601Wilbur A Lam · Emory University · R35 · FY2022 · HL
An Automated Platform for High-throughput Network Electrophysiology
$769,587James Ross · Axion Biosystems, Llc · R44 · FY2013 · NS
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
$769,579Christian C Melander · University Of Notre Dame · R01 · FY2022 · AI
Hybrid Rat Diversity Program
$769,547Melinda R Dwinell · Medical College Of Wisconsin · R24 · FY2020 · OD
Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens
$769,543Joseph C Wu · Stanford University · R01 · FY2025 · HL
Intensive longitudinal study of suicidal behaviors and related health outcomes
$769,532Matthew K Nock · Harvard University · U01 · FY2019 · MH
Intensive longitudinal study of suicidal behaviors and related health outcomes
$769,532Matthew K Nock · Harvard University · U01 · FY2020 · MH
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank
$769,444William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Development of dual effective kinase inhibitors as syndromic treatment of Giardiasis and Cryptosporidiosis
$769,365Kayode K Ojo · University Of Washington · R01 · FY2024 · AI
Protozoan Population Genetics and Inflammation
$769,313Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Development and Testing of Hsp90 Inhibitors
$769,259Leonard Petrucelli · Mayo Clinic Jacksonville · U01 · FY2012 · NS
Longitudinal Discovery of Brain Developmental Trajectories
$769,224Michael Peter Milham · Nathan S. Kline Institute For Psych Res · U01 · FY2013 · MH
Human Genetic determinants of HBV recovery
$769,106David L Thomas · Johns Hopkins University · R01 · FY2025 · AI
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
$769,087John C Newman · Buck Institute For Research On Aging · R01 · FY2023 · AG
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
$769,087John C Newman · Buck Institute For Research On Aging · R01 · FY2022 · AG
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
$769,087John C Newman · Buck Institute For Research On Aging · R01 · FY2021 · AG
Using geroscience to understand and treat Alzheimer's disease
$769,073Pamela Anne Maher · Salk Institute For Biological Studies · R01 · FY2024 · AG
Epigenetics of severe asthma
$769,008Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2020 · HL
Plasmodium Protein Kinase Focused Antimalarials Discovery
$769,003Debopam Chakrabarti · University Of Central Florida · R01 · FY2023 · AI
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD
$768,999Ani Wang Manichaikul · University Of Virginia · R01 · FY2021 · HL
Mechanisms of Chromosome Maintenance in Bacteria
$768,949Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic risk
$768,936Ginger E Nicol · Washington University · R01 · FY2021 · MH
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
$768,804Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2023 · HL
HIV incidence testing in an evolving epidemic: Identification of accurate multi-assay algorithms that include serosignatures from a novel antibody profiling system.
$768,641Susan H Eshleman · Johns Hopkins University · R01 · FY2017 · AI
New antifungals targeting the synthesis of fungal sphingolipids
$768,609Maurizio Del Poeta · State University New York Stony Brook · R01 · FY2022 · AI